title: Therapeutic serum concentrations of daptomycin after intraperitoneal administration in a patient with peritoneal dialysis-associated peritonitis.
authors.forename: Svenja K
authors.initials: SK
authors.lastname: Bahte
authors.forename: Anna
authors.initials: A
authors.lastname: Bertram
authors.forename: Olaf
authors.initials: O
authors.lastname: Burkhardt
authors.forename: Jens
authors.initials: J
authors.lastname: Martens-Lobenhoffer
authors.forename: Vega
authors.initials: V
authors.lastname: Goedecke
authors.forename: Stefanie M
authors.initials: SM
authors.lastname: Bode-Böger
authors.forename: Marcus
authors.initials: M
authors.lastname: Hiss
authors.forename: Jan T
authors.initials: JT
authors.lastname: Kielstein
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D017576:Daptomycin / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged; D009934:Organization and Administration; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy*; D044967:Serum / Q000737:chemistry*
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin